|
?:authorAffiliation
|
-
[\'Cochrane France, Paris, France.\', \'Université de Paris, INSERM, INRAE, CNAM, CRESS, Paris, France.\', \'Centre d\'Epidémiologie Clinique, AP-HP, Hôpital Hôtel Dieu, Paris, France.\', \'Cochrane Response, Cochrane, Berlin, Germany.\', \'Cochrane Response, Cochrane, Toronto, Canada.\', \'Cochrane Response, Cochrane, London, UK.\', \'Infectious Diseases and General Medicine, Mater Misercordiae University Hospital, Dublin, Ireland.\', \'Evidence Synthesis Ireland, Cochrane Ireland and HRB-Trials Methodology Research Network, National University of Ireland, Galway, Ireland.\', \'Institute for Evidence in Medicine, Medical Center & Faculty of Medicine, University of Freiburg, Freiburg, Germany.\', \'Cochrane Germany, Cochrane Germany Foundation, Freiburg, Germany.\', \'Epistemonikos Foundation, Santiago, Chile.\', \'UC Evidence Center, Cochrane Chile Associated Center, Pontificia Universidad Católica de Chile, Santiago, Chile.\', \'Centre for Evidence-Based Medicine Odense (CEBMO) and Cochrane Denmark, Department of Clinical Research, University of Southern Denmark, Odense, Denmark.\', \'Open Patient data Exploratory Network (OPEN), Odense University Hospital, Odense, Denmark.\', \'Department of Anesthesia, Intensive Care and Emergency, Fondazione IRCCS Ca\' Granda Ospedale Maggiore Policlinico, Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}